The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds

Familial Cancer

Volumn 4, Issue 2, 2005, Pages 177-181

  Siddiqui, Rina ^a   Onel, Kenan ^c   Facio, Flavia ^a   Nafa, Kedoudja ^a   Diaz, Louis Robles ^b   Kauff, Noah ^a   Huang, Helen ^a   Robson, Mark ^a   Ellis, Nathan ^a   Offit, Kenneth ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

1100delC; CHEK2; Germline mutations; Li Fraumeni syndrome; Polymorphism; TP53

Indexed keywords

CHECKPOINT KINASE 2; PROTEIN P53;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; MALE; MIDDLE AGED; PEDIGREE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES;

EID: 21244449269     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-004-1946-5     Document Type: Article

References (19)

1. FP Li JF Fraumeni Jr JJ. Mulvihill 1988 A cancer family syndrome in twenty-four kindreds Cancer Res 48 5358 62
2. D Malkin FP Li LC. Strong 1990 Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 233 8
3. FP Li JF. Fraumeni Jr 1969 Soft-tissue sarcomas, breast cancer, and other neoplasms A familial syndrome? Ann Intern Med 71 747 52
4. JM Birch AL Hartley KJ. Tricker 1994 Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families Cancer Res 54 1298 304
5. RA. Eeles 1995 Germline mutations in the TP53 gene Cancer Surv 25 101 24
6. JM Varley G McGown M. Thorncroft 1997 Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families Cancer Res 57 3245 52
7. JM Varley DG Evans JM. Birch 1997 Li-Fraumeni syndrome, a molecular and clinical review Br J Cancer 76 1 14
8. SY Shieh J Ahn K. Tamai 2000 The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites Genes Dev 14 289 300
9. DW Bell JM Varley TE. Szydlo 1999 Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome Science 286 2528 31
10. SB Lee SH Kim DW. Bell 2001 Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni syndrome Cancer Res 61 8062 67
11. P Vahteristo A Tamminen P. Karvinen 2001 p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition Cancer Res 61 5718 22
12. K Offit H Pierce T. Kirchhoff 2003 Frequency of CHEK2*1100delC in New York breast cancer cases and controls BMC Med Genet 4 1
13. T Hernandez-Boussard P Rodriguez-Tome R. Montesano 1999 IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines International Agency for Research on Cancer. Hum Mutat 14 1 8
14. AJ Levine J Momand CA. Finlay 1991 The p53 tumor suppressor gene Nature 351 453 6
15. AJ. Levine 1997 p53, the cellular gatekeeper for growth and division Cell 88 323 31
16. The CHEK2 Breast Cancer Case-Control Consortium. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 2004; 74: 1175-82
17. H Meijers-Heijboer A van den Ouweland J. Klijn 2002 Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations Nat Genet 31 55 9
18. EH Seppala T Ikonen N. Mononen 2003 CHEK2 variants associate with hereditary prostate cancer Br J Cancer 89 1966 70
19. P Dumont JI Leu AC. Della Pietra 2003 The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat Genet 33 357 65